PapersPMID:21566261
Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans.
- findings
- 2
- compound
- 1
- endpoints
- 2
- no difference found
- 1
- Study, every finding
- RCT · 12 months
- Dose studied, every finding
- 50 mg DHEA once daily for 12 months
What moved
How to read these marks →- Decreases triglycerides
moderate
“DHEA replacement resulted in a significant decrease in plasma triglycerides (DHEA: 120±10 mg/dl to 105±8 mg/dl; Placebo: 103±8 mg/dl to 110±8 mg/dl; p<0.05 within DHEA group; p<0.05 between groups).”
- Population
- men and women aged 65-75 without known diabetes; multivitamin and calcium/vitamin D supplements given to both arms
What did not
“Changes in the areas under the curve for glucose and insulin did not differ significantly between the placebo group (panels A and B) and the DHEA group (panels C and D) (glucose, p=0.09; insulin, p=0.52).”
- Population
- men and women aged 65-75 without known diabetes (16 found diabetic on the baseline OGTT and kept in); multivitamin and calcium/vitamin D supplements given to both arms
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- men and women aged 65-75 y from the Saint Louis area; 1-year randomized double-blind trial followed by a 12-mo open-label extension
- Participants
- 136
- Comparator
- placebo
- Duration
- 365 days
- Endpoints measured
- 84